chr17-81935110-C-T

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PM5PP5_Very_Strong

The NM_006907.4(PYCR1):​c.356G>A​(p.Arg119His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,609,820 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R119G) has been classified as Pathogenic.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000010 ( 0 hom. )

Consequence

PYCR1
NM_006907.4 missense

Scores

10
8
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:8

Conservation

PhyloP100: 7.63
Variant links:
Genes affected
PYCR1 (HGNC:9721): (pyrroline-5-carboxylate reductase 1) This gene encodes an enzyme that catalyzes the NAD(P)H-dependent conversion of pyrroline-5-carboxylate to proline. This enzyme may also play a physiologic role in the generation of NADP(+) in some cell types. The protein forms a homopolymer and localizes to the mitochondrion. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 12 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr17-81935111-G-C is described in Lovd as [Pathogenic].
PP5
Variant 17-81935110-C-T is Pathogenic according to our data. Variant chr17-81935110-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 13197.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-81935110-C-T is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PYCR1NM_006907.4 linkc.356G>A p.Arg119His missense_variant Exon 4 of 7 ENST00000329875.13 NP_008838.2 P32322-1A0A024R8U9Q8TBX0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PYCR1ENST00000329875.13 linkc.356G>A p.Arg119His missense_variant Exon 4 of 7 1 NM_006907.4 ENSP00000328858.8 P32322-1

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152202
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000122
AC:
3
AN:
246834
Hom.:
0
AF XY:
0.0000149
AC XY:
2
AN XY:
134344
show subpopulations
Gnomad AFR exome
AF:
0.0000625
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000179
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000103
AC:
15
AN:
1457500
Hom.:
0
Cov.:
33
AF XY:
0.0000110
AC XY:
8
AN XY:
725160
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000117
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152320
Hom.:
0
Cov.:
33
AF XY:
0.0000537
AC XY:
4
AN XY:
74478
show subpopulations
Gnomad4 AFR
AF:
0.000168
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000652
Hom.:
0
Bravo
AF:
0.0000264
ExAC
AF:
0.0000247
AC:
3
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:3
Jun 05, 2023
GeneDx
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Functional studies using recombinant protein expressed and purified in E.coli showed negligible enzyme activity (Li et al., 2017); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 18348262, 19648921, 30450527, 28194412) -

Jun 17, 2021
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Aug 04, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 119 of the PYCR1 protein (p.Arg119His). This variant is present in population databases (rs121918377, gnomAD 0.007%). This missense change has been observed in individuals with autosomal recessive cutis laxa (PMID: 19648921, 23963297, 30450527). ClinVar contains an entry for this variant (Variation ID: 13197). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PYCR1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects PYCR1 function (PMID: 28194412). This variant disrupts the p.Arg119 amino acid residue in PYCR1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 23963297, 24035636, 25865492, 30450527). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -

Autosomal recessive cutis laxa type 2B Pathogenic:2
Sep 01, 2009
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Jan 20, 2020
Baylor Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. -

PYCR1-related de Barsy syndrome Pathogenic:1
Dec 30, 2017
Department Of Genetics, Sultan Qaboos University Hospital, Sultan Qaboos University
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: curation

- -

Cutis laxa Pathogenic:1
Jan 29, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: PYCR1 c.356G>A (p.Arg119His) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 246834 control chromosomes. c.356G>A has been reported in the literature in multiple individuals affected with Cutis Laxa - PYCR1 Related (Reversade_2017). These data indicate that the variant is very likely to be associated with disease. A different variant affecting the same codon has been classified as pathogenic by our lab (c.355C>T, p.Arg119Cys), supporting the critical relevance of codon 119 to PYCR1 protein function. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal activity (Li_2017). The following publications have been ascertained in the context of this evaluation (PMID: 28194412, 19648921). ClinVar contains an entry for this variant (Variation ID: 13197). Based on the evidence outlined above, the variant was classified as pathogenic. -

Wiedemann-Rautenstrauch-like progeroid syndrome Pathogenic:1
-
University of Washington Center for Mendelian Genomics, University of Washington
Significance: Likely pathogenic
Review Status: no assertion criteria provided
Collection Method: research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.87
BayesDel_addAF
Pathogenic
0.22
D
BayesDel_noAF
Pathogenic
0.26
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.80
D;.;.;.;D;.;T;.;T;T;T;.;T;T
Eigen
Uncertain
0.68
Eigen_PC
Uncertain
0.53
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.91
.;D;D;D;D;.;D;D;D;D;D;D;D;D
M_CAP
Pathogenic
0.37
D
MetaRNN
Uncertain
0.71
D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
0.58
D
MutationAssessor
Pathogenic
4.4
H;H;.;.;H;.;.;.;.;.;.;.;.;.
PrimateAI
Uncertain
0.61
T
PROVEAN
Pathogenic
-4.9
D;D;D;.;.;.;.;D;.;N;.;.;.;.
REVEL
Pathogenic
0.65
Sift
Uncertain
0.0050
D;D;D;.;.;.;.;D;.;T;.;.;.;.
Sift4G
Pathogenic
0.0
D;D;D;D;D;D;D;D;.;D;.;.;D;.
Polyphen
0.99
D;.;.;.;D;.;.;.;.;.;.;.;.;.
Vest4
0.97
MVP
0.78
MPC
0.51
ClinPred
0.99
D
GERP RS
4.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.78
gMVP
0.93

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs121918377; hg19: chr17-79892986; API